Sector
PharmaceuticalsOpen
₹215Prev. Close
₹217.79Turnover(Lac.)
₹278.77Day's High
₹223.44Day's Low
₹213.9152 Week's High
₹307.9852 Week's Low
₹133Book Value
₹258.32Face Value
₹2Mkt Cap (₹ Cr.)
3,456.28P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 31.36 | 31.36 | 31.36 | 31.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4,021.22 | 4,082.95 | 4,200.42 | 4,643.26 |
Net Worth | 4,052.58 | 4,114.31 | 4,231.78 | 4,674.62 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 208.01 | 580.74 | 474.46 | 451.49 |
yoy growth (%) | -64.18 | 22.4 | 5.08 | 6,529.8 |
Raw materials | -108.44 | -200.11 | -155.31 | -142.07 |
As % of sales | 52.13 | 34.45 | 32.73 | 31.46 |
Employee costs | -59.4 | -88.87 | -61.67 | -66.76 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -168.69 | 55.46 | 62.17 | 43.91 |
Depreciation | -143.21 | -140.65 | -134.45 | -135.85 |
Tax paid | -64.12 | -16.94 | -25.1 | -19.67 |
Working capital | 0.78 | 29.87 | 52.04 | 419.05 |
Other operating items |
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 2,615.77 | 2,412.92 | 2,140.69 | 1,912.03 | 2,043.6 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,615.77 | 2,412.92 | 2,140.69 | 1,912.03 | 2,043.6 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 28.21 | 27.77 | 43.42 | 38.45 | 44.46 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,698.35 | 129.24 | 4,07,155.15 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,549.7 | 71.05 | 1,47,295.24 | 594 | 0.54 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,444.25 | 25.07 | 1,16,664.33 | 1,438.15 | 0.9 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183.9 | 59.03 | 1,07,673.27 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,458.1 | 52.42 | 1,01,358.17 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Janmejay R Vyas
Whole-time Director
Deohooti J Vyas
Managing Director & CFO
Arpit J Vyas
Independent Director
Subir Kumar Das
Independent Director
Rajendra S Shah
Company Sec. & Compli. Officer
Shrima Dave
Independent Director
Maitri K Mehta
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dishman Carbogen Amcis Ltd
Summary
Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007. The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCLs subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure. The name of Carbogen Amcis (India) Ltd. was changed to Dishman Carbogen Amcis Ltd. with effect from Dishman Pharmaceuticals and Chemicals Ltd was incorporated in the year 1983 as a research-oriented organization. The company set up their first manufacturing unit in Naroda for phase Transfer Catalysts. The company earned the status of Quat Company by establishing themselves in the Quat business.In the year 1995, the company formed a joint venture company with Schtz & Co, Germany called as Schutz Dishman Biotech Private Ltd. They manufacture Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate so
Read More
The Dishman Carbogen Amcis Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹220.45 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dishman Carbogen Amcis Ltd is ₹3456.28 Cr. as of 01 Apr ‘25
The PE and PB ratios of Dishman Carbogen Amcis Ltd is 0 and 0.84 as of 01 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Dishman Carbogen Amcis Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dishman Carbogen Amcis Ltd is ₹133 and ₹307.98 as of 01 Apr ‘25
Dishman Carbogen Amcis Ltd's CAGR for 5 Years at 33.77%, 3 Years at 5.16%, 1 Year at -7.54%, 6 Month at 20.94%, 3 Month at -18.47% and 1 Month at 9.33%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.